Optical Coherence Tomography (OCT) Data Collection Study
Optical Coherence Tomography Data Collection Study
1 other identifier
observational
400
2 countries
5
Brief Summary
Collect OCT data to evaluate the range and age trend of eye measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2011
Shorter than P25 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 23, 2011
CompletedFirst Posted
Study publicly available on registry
October 26, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedMay 2, 2012
May 1, 2012
6 months
October 23, 2011
May 1, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
range of eye measurements
Day 1
Secondary Outcomes (1)
age trend of eye measurements
Day 1
Study Arms (6)
Age 18-29
Age 30-39
Age 40-49
Age 50-59
Age 60-69
Age 70+
Eligibility Criteria
No eye disease
You may qualify if:
- At least 18 years of age
- Able and willing to provide consent
- Able and willing to complete the required examininations and visit
- Refractive error within 8 diopters sphere and within 2 diopters cylinder in each eye
- Best corrected visual acuity of 20/30 or better in each eye
You may not qualify if:
- History of leukemia, AIDS, dementia or multiple sclerosis
- Concomitant use of hydroxycloroquine or chloroquine
- Family history of glaucoma among first degree relatives
- Intraocular pressure of 22mm Hg or greater in either eye
- Unreliable or abnormal visual field
- Active ocular disease
- Previously diagnosed with glaucoma or glaucoma suspect
- Congenital ocular abnormalities
- Previous intra-ocular surgery or laser treatment (other than refractive surgery or uncomplicated cataract surgery greater than 6 months previously)
- Anatomic narrow angle
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Optovuelead
Study Sites (5)
Southern California College of Optometry
Fullerton, California, 92831, United States
College of Optometry, Western University of Health Sciences
Pomona, California, 91766, United States
Buena Vista Eye Care
San Jose, California, 95112, United States
Illinois Eye Institute
Chicago, Illinois, 60616, United States
Institute of Ophthalmology, University College London
London, England, EC1V 9EL, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
George Comer, OD, MBA
Southern California College of Optometry at Marshall B. Ketchum University
- PRINCIPAL INVESTIGATOR
Michael Chaglasian, OD
Illinois Eye Institute
- PRINCIPAL INVESTIGATOR
Jorge Cuadros, OD, PhD
Buena Vista Eye Care
- PRINCIPAL INVESTIGATOR
David Garway-Heath, MD
Institute of Ophthalmology, University College London
- PRINCIPAL INVESTIGATOR
Pinakin G Davey, OD, PhD
Western University of Health Sciences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2011
First Posted
October 26, 2011
Study Start
September 1, 2011
Primary Completion
March 1, 2012
Study Completion
March 1, 2012
Last Updated
May 2, 2012
Record last verified: 2012-05